Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ciwujia Granules in Chronic Fatigue Syndrome
NCT06245642Phase 4Completed
- Sponsor
- Heilongjiang Quanle Pharmaceutical
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eleuthero in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Heilongjiang Quanle Pharmaceutical. Started Mar 2024; status: completed.
02
Drugs
eleuthero
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT06245642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06245642.